发布求助
文献互助 智能选刊 最新文献

Clinical Lymphoma, Myeloma & Leukemia最新文献

筛选
英文 中文
OA-49 Phase 3 Study Results of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus VRd for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (IMROZ) 伊沙妥昔单抗、硼替佐米、来那度胺和地塞米松（Isa-VRd）与VRd治疗新诊断多发性骨髓瘤（IMROZ）移植不合格患者的OA-49 3期研究结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01890-1
Thierry Facon, Meletios Dimopoulos, Xavier Leleu, Meral Beksac, Ludek Pour, Roman Hájek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko-Jarosinska, Ivan Spicka, Vladimir Vorobyev, Michele Cavo, Hartmut Goldschmidt, Thomas Martin, Salomon Manier, Marie-France Brégeault, Sandrine Macé, Christelle Berthou, Robert Orlowski
{"title":"OA-49 Phase 3 Study Results of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus VRd for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (IMROZ)","authors":"Thierry Facon, Meletios Dimopoulos, Xavier Leleu, Meral Beksac, Ludek Pour, Roman Hájek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko-Jarosinska, Ivan Spicka, Vladimir Vorobyev, Michele Cavo, Hartmut Goldschmidt, Thomas Martin, Salomon Manier, Marie-France Brégeault, Sandrine Macé, Christelle Berthou, Robert Orlowski","doi":"10.1016/S2152-2650(24)01890-1","DOIUrl":"10.1016/S2152-2650(24)01890-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S31"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-013 CERVINO: A Phase 3, Multicenter, Randomized, Open-Label Study of ABBV-383 Compared With Standard Available Therapies in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) P-013 CERVINO：ABBV-383与现有标准疗法在复发性或难治性多发性骨髓瘤（RRMM）患者中的3期、多中心、随机、开放标签研究
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01916-5
Luciano Costa, María-Victoria Mateos Manteca, Peter M. Voorhees, Shinsuke Iida, Craig Cole, Hang Quach, Rajvineeth Pothacamury, Orlando Bueno, Shane Lee, Tanya Rosenberg, Chetasi Talati, Shaji Kumar
{"title":"P-013 CERVINO: A Phase 3, Multicenter, Randomized, Open-Label Study of ABBV-383 Compared With Standard Available Therapies in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)","authors":"Luciano Costa, María-Victoria Mateos Manteca, Peter M. Voorhees, Shinsuke Iida, Craig Cole, Hang Quach, Rajvineeth Pothacamury, Orlando Bueno, Shane Lee, Tanya Rosenberg, Chetasi Talati, Shaji Kumar","doi":"10.1016/S2152-2650(24)01916-5","DOIUrl":"10.1016/S2152-2650(24)01916-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S47-S48"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-032 Real-World Analysis of Teclistamab Treatment for Relapsed Refractory Multiple Myeloma in Two Belgian University Hospitals P-032 比利时两所大学医院对替卡单抗治疗复发难治多发性骨髓瘤的真实世界分析
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01935-9
Gaspard Jadot, Julien Depaus, Marie-Christiane Vekemans
{"title":"P-032 Real-World Analysis of Teclistamab Treatment for Relapsed Refractory Multiple Myeloma in Two Belgian University Hospitals","authors":"Gaspard Jadot, Julien Depaus, Marie-Christiane Vekemans","doi":"10.1016/S2152-2650(24)01935-9","DOIUrl":"10.1016/S2152-2650(24)01935-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S59"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-06 Impact of Clonal Hematopoiesis on Clinical Outcomes to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma OA-06 克隆造血对多发性骨髓瘤 BCMA 导向 CAR T 细胞疗法临床疗效的影响
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01847-0
Joshua Gustine, Andrew Branagan, Diana Cirstea, Farah Rexha, Ryan Han, Andrew Yee, Matthew Frigault, Noopur Raje
{"title":"OA-06 Impact of Clonal Hematopoiesis on Clinical Outcomes to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma","authors":"Joshua Gustine, Andrew Branagan, Diana Cirstea, Farah Rexha, Ryan Han, Andrew Yee, Matthew Frigault, Noopur Raje","doi":"10.1016/S2152-2650(24)01847-0","DOIUrl":"10.1016/S2152-2650(24)01847-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S4-S5"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-08 Safety and Preliminary Efficacy of BMS-986393, a GPRC5D CAR T Cell Therapy, in Patients (pts) With Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1–3 Prior Regimens: Results From a Phase 1 Study OA-08 GPRC5D CAR T细胞疗法BMS-986393在复发/难治性（RR）多发性骨髓瘤（MM）患者（pts）中的安全性和初步疗效：1期研究结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01849-4
Myo Htut, Omar Nadeem, Jesus Berdeja, Larry Anderson, Adriana Rossi, Tara Gregory, Thomas Martin, Luciano Costa, Hongxiang Hu, Chaoqun Mei, Alok Shrestha, Safiyyah Ziyad, Wei-Ming Kao, Allison Kaeding, Michael Burgess, Susan Bal
{"title":"OA-08 Safety and Preliminary Efficacy of BMS-986393, a GPRC5D CAR T Cell Therapy, in Patients (pts) With Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1–3 Prior Regimens: Results From a Phase 1 Study","authors":"Myo Htut, Omar Nadeem, Jesus Berdeja, Larry Anderson, Adriana Rossi, Tara Gregory, Thomas Martin, Luciano Costa, Hongxiang Hu, Chaoqun Mei, Alok Shrestha, Safiyyah Ziyad, Wei-Ming Kao, Allison Kaeding, Michael Burgess, Susan Bal","doi":"10.1016/S2152-2650(24)01849-4","DOIUrl":"10.1016/S2152-2650(24)01849-4","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S5-S6"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-016 Comparative Efficacy of CARVYKTI in CARTITUDE-4 versus Alternative Treatments from Daratumumab Clinical Trials for the Treatment of Patients with Lenalidomide-Refractory Multiple Myeloma P-016 CARVYKTI在CARTITUDE-4中的疗效与达拉单抗临床试验中治疗来那度胺难治性多发性骨髓瘤患者的替代疗法比较
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01919-0
Michel Delforge, Irit Avivi, María-Victoria Mateos Manteca, Kristina Carlson, João Mendes, Seina Lee, Keqin Qi, Jordan Schecter, William Deraedt, Carolina Lonardi, Ana Slaughter, Diana Chen, Man Zhao, Kaitlyn Connors, Nitin Patel, Erika Florendo, Hermann Einsele, Binod Dhakal, Wilfried Roeloffzen
{"title":"P-016 Comparative Efficacy of CARVYKTI in CARTITUDE-4 versus Alternative Treatments from Daratumumab Clinical Trials for the Treatment of Patients with Lenalidomide-Refractory Multiple Myeloma","authors":"Michel Delforge, Irit Avivi, María-Victoria Mateos Manteca, Kristina Carlson, João Mendes, Seina Lee, Keqin Qi, Jordan Schecter, William Deraedt, Carolina Lonardi, Ana Slaughter, Diana Chen, Man Zhao, Kaitlyn Connors, Nitin Patel, Erika Florendo, Hermann Einsele, Binod Dhakal, Wilfried Roeloffzen","doi":"10.1016/S2152-2650(24)01919-0","DOIUrl":"10.1016/S2152-2650(24)01919-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S49"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-01 Talquetamab (tal) + Daratumumab (dara) + Pomalidomide (pom) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 1b TRIMM-2 Study OA-01 Talquetamab (tal) + Daratumumab (dara) + Pomalidomide (pom) 用于复发性/难治性多发性骨髓瘤 (RRMM) 患者 (pts)：TRIMM-2 1b 期研究结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01842-1
Nizar J. Bahlis, Niels van de Donk, Donna Reece, Manisha Bhutani, Bhagirathbhai Dholaria, Anita D'Souza, Thomas Martin, John McKay, Alfred Garfall, Amrita Krishnan, Kalpana Bakshi, Lijuan Kang, Lien Vandenberk, Thomas Prior, Jaszianne Tolbert, Ajai Chari
{"title":"OA-01 Talquetamab (tal) + Daratumumab (dara) + Pomalidomide (pom) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 1b TRIMM-2 Study","authors":"Nizar J. Bahlis, Niels van de Donk, Donna Reece, Manisha Bhutani, Bhagirathbhai Dholaria, Anita D'Souza, Thomas Martin, John McKay, Alfred Garfall, Amrita Krishnan, Kalpana Bakshi, Lijuan Kang, Lien Vandenberk, Thomas Prior, Jaszianne Tolbert, Ajai Chari","doi":"10.1016/S2152-2650(24)01842-1","DOIUrl":"10.1016/S2152-2650(24)01842-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S1"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-02 Multiplex CRISPR/Cas9 Genome Editing of Cord Blood-derived CAR NK Cells to Improve Their Persistence and Antitumoral Potential Against Multiple Myeloma OA-02 对脐带血 CAR NK 细胞进行多重 CRISPR/Cas9 基因组编辑，提高其持久性和抗多发性骨髓瘤的潜力
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01843-3
Eva Castellano, Almudena García-Ortiz, Laura Ugalde, Elena Maroto-Martin, Jessica Encinas, Raquel Oliva, Laura García-García, Noemí Álvarez, Gonzalo Carreño, Rosa Ayala, Laura Córdoba, Alejandra Leivas, Guillermo Suñé, Rafael Alonso Fernández, Maria Teresa Cedena, Beatriz Martín-Antonio, Joaquín Martínez-Lopez, Paula Río, Antonio Valeri
{"title":"OA-02 Multiplex CRISPR/Cas9 Genome Editing of Cord Blood-derived CAR NK Cells to Improve Their Persistence and Antitumoral Potential Against Multiple Myeloma","authors":"Eva Castellano, Almudena García-Ortiz, Laura Ugalde, Elena Maroto-Martin, Jessica Encinas, Raquel Oliva, Laura García-García, Noemí Álvarez, Gonzalo Carreño, Rosa Ayala, Laura Córdoba, Alejandra Leivas, Guillermo Suñé, Rafael Alonso Fernández, Maria Teresa Cedena, Beatriz Martín-Antonio, Joaquín Martínez-Lopez, Paula Río, Antonio Valeri","doi":"10.1016/S2152-2650(24)01843-3","DOIUrl":"10.1016/S2152-2650(24)01843-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S1-S2"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-005 Effectiveness of Bridging Therapy Corresponds to Improved Outcomes After Receiving CAR-T Therapy: Phase 3 CARTITUDE-4 Study of Patients With Relapsed, Lenalidomide-Refractory Multiple Myeloma P-005 桥接疗法的有效性与接受CAR-T疗法后的疗效改善相对应：复发、来那度胺难治性多发性骨髓瘤患者的3期CARTITUDE-4研究
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01908-6
Sébastien Anguille, Xavier Leleu, Moshe Gatt, Lionel Karlin, Andrew Spencer, Shinsuke Iida, Tadao Ishida, Yi Lin, Chang-Ki Min, Seok Jin Kim, Ana Slaughter, Carolina Lonardi, Nina Benachour, Martin Vogel, Vicki Plaks, Katherine Li, Diana Chen, Quanlin Li, Tamar Lengil, Mythili Koneru, Hermann Einsele
{"title":"P-005 Effectiveness of Bridging Therapy Corresponds to Improved Outcomes After Receiving CAR-T Therapy: Phase 3 CARTITUDE-4 Study of Patients With Relapsed, Lenalidomide-Refractory Multiple Myeloma","authors":"Sébastien Anguille, Xavier Leleu, Moshe Gatt, Lionel Karlin, Andrew Spencer, Shinsuke Iida, Tadao Ishida, Yi Lin, Chang-Ki Min, Seok Jin Kim, Ana Slaughter, Carolina Lonardi, Nina Benachour, Martin Vogel, Vicki Plaks, Katherine Li, Diana Chen, Quanlin Li, Tamar Lengil, Mythili Koneru, Hermann Einsele","doi":"10.1016/S2152-2650(24)01908-6","DOIUrl":"10.1016/S2152-2650(24)01908-6","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S42-S43"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-007 Absolute Lymphocyte Count at Day 30 (Not Earlier) and Early CRS Predict Delayed Responses to Teclistamab: Results From the US Myeloma Immunotherapy Consortium P-007 第30天（而非更早）的绝对淋巴细胞计数和早期CRS可预测对替卡单抗的延迟反应：美国骨髓瘤免疫疗法联盟的研究结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01910-4
Rahul Banerjee, Gurbakhash Kaur, Beatrice Razzo, Andrew Portuguese, Surbhi Sidana, Tiffany Richards, Ariel Grajales-Cruz, Shambavi Richard, Leyla Shune, Jack Khouri, Danai Dima, Hans Lee, Krina Patel, Mariola Vazquez-Martinez, Doris Hansen, James Davis, Hamza Hashmi, Shebli Atrash, Christopher Ferreri, Kelley Julian, Alfred Garfall
{"title":"P-007 Absolute Lymphocyte Count at Day 30 (Not Earlier) and Early CRS Predict Delayed Responses to Teclistamab: Results From the US Myeloma Immunotherapy Consortium","authors":"Rahul Banerjee, Gurbakhash Kaur, Beatrice Razzo, Andrew Portuguese, Surbhi Sidana, Tiffany Richards, Ariel Grajales-Cruz, Shambavi Richard, Leyla Shune, Jack Khouri, Danai Dima, Hans Lee, Krina Patel, Mariola Vazquez-Martinez, Doris Hansen, James Davis, Hamza Hashmi, Shebli Atrash, Christopher Ferreri, Kelley Julian, Alfred Garfall","doi":"10.1016/S2152-2650(24)01910-4","DOIUrl":"10.1016/S2152-2650(24)01910-4","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S43-S44"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信